Titian Software launches Mosaic 4.0
News Apr 23, 2010
At SBS 2010 in Phoenix, Titian Software launched version 4.0 of its Mosaic Sample Management software. Mosaic is already established as the leading sample management software for small molecule compound libraries, and is used by ten of the top 20 pharma companies. Applications of the new Mosaic 4.0 are extended to the enterprise-wide management of biological samples and reagents in many different types of life science research organisations in industry and academia.
Mosaic 4.0 builds on the proven strengths of earlier versions, including modular scalability, advanced instrument integration, and comprehensive audit trail and genealogy tracking. In response to the specific requirements of biological sample management, Mosaic 4.0 now incorporates enhanced modules for tracking manually-accessed stores and manual operations, such as hand pipetting, for smaller-scale operations. A new built-in Substance Registration System handles the allocation of substance identifiers and the capture of substance metadata, and Mosaic can still seamlessly link to external registration systems if required. For higher-throughput laboratories, Mosaic 4.0 builds on its workflow management capability and wide array of integration modules for automated stores, liquid handlers and other instruments. The new functionality makes version 4.0 well-suited to the management of clinical trial samples and reagents, therapeutic and anti-drug antibodies (ADA), cell lines and biobank samples – in addition to small molecule compounds.
“The next generation Mosaic 4.0 was conceived in response to customer demand”, said Richard Fry, Titian’s Director of Business Development. “The new functionality to handle biological samples has been developed in close partnership with our customers in leading pharma and biotech companies, and I’m particularly pleased that the first installation of Mosaic 4.0 is in a validated environment in clinical trials. Our goal with version 4.0 is to build on our track record in compound management to establish Mosaic as the software of choice for the management of all sample types.”
Organizations looking to benefit from the artificial intelligence (AI) revolution should be cautious about putting all their eggs in one basket, a study published in Nature Machine Intelligence has found. Researchers found that contrary to conventional wisdom, there can be no exact method for deciding whether a given problem may be successfully solved by machine learning tools.READ MORE
The ideal drug is one that only affects the exact cells and neurons it is designed to treat, without unwanted side effects. This concept is especially important when treating the delicate and complex human brain. Now, scientists have revealed a mechanism that could lead to this kind of long-sought specificity for treatments of strokes and seizures.READ MORE